Metys Pharmaceuticals AG is a company that provides Chemotherapy-induced peripheral neuropathy, Dimiracetam, Medical equipment and more. Metys Pharmaceuticals AG is headquartered in Switzerland Basel-Stadt. Metys Pharmaceuticals AG was founded in 2013. Metys Pharmaceuticals AG has a total of 82 patents
Metys Pharmaceuticals is developing MP-101 to prevent and treat chemotherapy-induced peripheral neuropathy, an uncomfortable and troubling side effect...
What is Metys Pharmaceuticals AG's official website?